Technical / White Paper

Pharmaceutical Development for ADCs

Format: PDF file | Document type: Technical / White Paper | Promoted Content

This Technical / White Paper has been written by Baxter BioPharma Solutions , and any views and opinions expressed do not necessarily reflect those of

Pharmaceutical Development for ADCs

Formulation, process, and analytical development for antibody-drug conjugates, or ADCs, is complex.

While the development of an aqueous solution formulation may be preferred over a lyophilized product, it is useful to initially pursue a dual path and develop drug product formulations for both a sterile solution and a freeze-dried solid presentation, ultimately choosing the most successful candidate for final development.

This white paper provides an overview of:

  • ADC structure and function
  • The development process
  • Lyo cycle optimization 

Related resources from Baxter BioPharma Solutions

Supplier info centre